Curtailed two-stage designs in phase II clinical trials

Statistics in Medicine

Volumn 27, Issue 29, 2008, Pages 6175-6189

  Chi, Yunchan ^a   Chen, Chia Min ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Curtailed sampling procedure; Curtailed two stage designs; Expected sample size; Simon's two stage designs

Indexed keywords

ANTINEOPLASTIC AGENT; ETOPOSIDE;

ARTICLE; BIOMETRY; COMPARATIVE STUDY; DRUG DEVELOPMENT; HUMAN; KAPOSI SARCOMA; MANTLE CELL LYMPHOMA; METHODOLOGY; PHASE 2 CLINICAL TRIAL; STATISTICAL MODEL; STATISTICS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BIOMETRY; CLINICAL TRIALS, PHASE II AS TOPIC; DRUG DISCOVERY; ETOPOSIDE; HUMANS; LYMPHOMA, MANTLE-CELL; MODELS, STATISTICAL; SARCOMA, KAPOSI; STOCHASTIC PROCESSES; TREATMENT OUTCOME;

EID: 67650360822     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3424     Document Type: Article

References (10)

1. Evans SR, Krown SE, Testa MA, Cooley TP, Von Roenn JH. Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS clinical trials group clinical study. Journal of Clinical Oncology 2002; 20:3236-3241.
2. Simon R. Optimal two-stage designs for Phase II clinical trials. Controlled Clinical Trials 1989; 10:1-10.
3. Shuster J. Optimal two-stage designs for single arm Phase II cancer trials. Journal of Biopharmaceutical Statistics 2002; 12:39-51.
4. Ayanlowo AO, Redden DT. Stochastically curtailed Phase II clinical trials. Statistics in Medicine 2007; 26: 1462-1472.
5. Herrmann N, Szatrowski TH. Curtailed binomial sampling procedures for clinical trials with paired data. Controlled Clinical Trials 1985; 6:25-37.
6. Phatak AG, Bhatt NM. Estimation of the fraction defective in curtailed sampling plans by attributes. Technometrics 1967; 9:219-228.
7. Williams WW, Looney SW, Peters MH. Use of curtailed sampling plans in the economic design of np-control charts. Technometrics 1985; 27:57-63.
8. Yao TJ, Venkatraman ES. Optimal two-stage design for a series of pilot trials of new agents. Biometrics 1998; 54:1183-1189.
9. Patil GP. On the evaluation of the negative binomial distribution with examples. Technometrics 1960; 2:501-505.
10. Ruan J, Coleman M, Furman RR, Glynn P, Maureen J, Ketas J, Cheung K, Church S, Shore T, Feldman E, Rutherford S, Hyjek E, Chadburn A, Rafii S, Leonard JP. Targeting angiogenesis in mantle cell lymphoma: clinical efficacy and correlative studies of a Phase II trial of RT-PEPC (rituximab, thalidomide and metronomic oral chemotherapy with prednisone, etoposide, procarbazine and cyclophosphamide) in relapsed/refractory disease. Blood 2006; 108:2751.